Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 8월 30

ICU Medical Inc

ICUINASDAQ
Trade with Public
Trade with Public
$175.10
N/A
가까이에: Aug 28, 5:00 PM EST
$175.10
N/A
시간외: Aug 28, 4:00 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

ICU Medical Financials

ICU Medical (ICUI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.
Avi Kapoor

PRO
ICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 Est

ICU Medical (NASDAQ:ICUI) raises FY2026 Adj EPS guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 analyst estimate..
Benzinga Newsdesk

PRO
ICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 Est

ICU Medical (NASDAQ:ICUI) raises FY2026 GAAP EPS guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 analyst estimate..
Benzinga Newsdesk

PRO
ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 by 24.08 percent. This is a 12.86 percent increase over earnings of $2.10 per share from the
Benzinga Newsdesk

PRO
ICU Medical Affirms FY2026 GAAP EPS Guidance of $1.03-$1.74 vs $1.73 Est

ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $1.03-$1.74 to $1.03-$1.74 vs $1.73 analyst estimate..
Benzinga Newsdesk

PRO
ICU Medical Affirms FY2026 Adj EPS Guidance of $7.75-$8.45 vs $8.09 Est

ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $7.75-$8.45 to $7.75-$8.45 vs $8.09 analyst estimate..
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved